Novo Nordisk (NVO) Stock: Rises as U.K. Clears Higher Wegovy Dose

TLDR The U.K. approved a higher 7.2 mg weekly dose of Wegovy for obesity patients, up from the previous 2.4 mg limit, administered as three separate injections. Novo Nordisk’s oral Wegovy pill launched in the U.S. on January 5 and recorded 3,071 prescriptions in its first four days on the market. Berenberg analysts estimate the [...]

The post Novo Nordisk (NVO) Stock: Rises as U.K. Clears Higher Wegovy Dose appeared first on Blockonomi.